Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, December 4, 2020
[ Fri, Dec 04th 2020
] - WOPRAI
[ Fri, Dec 04th 2020
] - WOPRAI
[ Fri, Dec 04th 2020
] - WOPRAI
[ Fri, Dec 04th 2020
] - WOPRAI
[ Fri, Dec 04th 2020
] - WOPRAI
[ Fri, Dec 04th 2020
] - WOPRAI
[ Fri, Dec 04th 2020
] - WOPRAI
[ Fri, Dec 04th 2020
] - WOPRAI
[ Fri, Dec 04th 2020
] - WOPRAI
[ Fri, Dec 04th 2020
] - WOPRAI
[ Fri, Dec 04th 2020
] - WOPRAI
[ Fri, Dec 04th 2020
] - WOPRAI
[ Fri, Dec 04th 2020
] - WOPRAI
Thu, December 3, 2020
[ Thu, Dec 03rd 2020
] - WOPRAI
[ Thu, Dec 03rd 2020
] - WOPRAI
[ Thu, Dec 03rd 2020
] - WOPRAI
[ Thu, Dec 03rd 2020
] - WOPRAI
[ Thu, Dec 03rd 2020
] - WOPRAI
[ Thu, Dec 03rd 2020
] - WOPRAI
[ Thu, Dec 03rd 2020
] - WOPRAI
[ Thu, Dec 03rd 2020
] - WOPRAI
[ Thu, Dec 03rd 2020
] - WOPRAI
[ Thu, Dec 03rd 2020
] - WOPRAI
[ Thu, Dec 03rd 2020
] - WOPRAI
[ Thu, Dec 03rd 2020
] - WOPRAI
[ Thu, Dec 03rd 2020
] - WOPRAI
[ Thu, Dec 03rd 2020
] - WOPRAI
Konstantinos Aprilakis Initiated (ADCT) at Hold and Held Target at $42 on, Dec 3rd, 2020
Konstantinos Aprilakis of Stifel, Initiated "ADC Therapeutics SA" (ADCT) at Hold and Held Target at $42 on, Dec 3rd, 2020.
Konstantinos has made no other calls on ADCT in the last 4 months.
There are 2 other peers that have a rating on ADCT. Out of the 2 peers that are also analyzing ADCT, 0 agree with Konstantinos's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Konstantinos
- Robert Burns of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $47 on, Thursday, October 29th, 2020
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $52 on, Tuesday, October 13th, 2020
